Rebecca Guntern Flückiger
Director/Board Member at BKW AG
Net worth: 403 893 $ as of 2024-05-30
Profile
Rebecca Guntern Flückiger is currently the Chairman at Sandoz A and the Director at Intergenerika.
She is also the Head-Cluster Europe at Sandoz Pharmaceuticals AG since 2008, a Member-Supervisory Board at BKW AG since 2018, the President-Europe Region at Sandoz Group AG since 2022, and the Vice President at Medicines For Europe.
Previously, she served as a Director at SSE Holding SA from 2016 to 2019.
Ms. Guntern Flückiger completed her undergraduate and graduate degrees at the University of Basel.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BKW AG
0.00% | 2023-12-30 | 2,566 ( 0.00% ) | 403 893 $ | 2024-05-30 |
Rebecca Guntern Flückiger active positions
| Companies | Position | Start |
|---|---|---|
| BKW AG | Director/Board Member | 2018-05-17 |
| SANDOZ GROUP AG | Corporate Officer/Principal | 2022-01-16 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | 2007-12-31 |
| Intergenerika | Director/Board Member | - |
Sandoz A/S
 Sandoz A/S Drugstore ChainsRetail Trade Sandoz A/S engages in sale and distribution of pharmaceutical products. It offers a variety of prescription medicines, Over-the-Counter medicines, and biopharmaceuticals. The company was founded in 2004 and is headquartered in Copenhagen, Denmark. | Chairman | - |
| Medicines For Europe | Corporate Officer/Principal | - |
Former positions of Rebecca Guntern Flückiger
| Companies | Position | End |
|---|---|---|
Société Suisse des Explosifs SA
 Société Suisse des Explosifs SA Chemicals: SpecialtyProcess Industries SSE Holding SA engages in the manufacturing and distribution of civil explosives and fine chemicals. It is also involved in the production and commercialization of explosives and provision of drilling and blasting services, as well as specialization in custom synthesis and contract manufacturing for the chemical and pharmaceutical industries. The company was founded in 1894 and is headquartered in Brig, Switzerland. | Director/Board Member | 2019-04-30 |
Training of Rebecca Guntern Flückiger
| University of Basel | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
 | Process Industries |
| BKW AG | Utilities |
| SANDOZ GROUP AG | Health Technology |
| Private companies | 4 |
|---|---|
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Sandoz A/S
Sandoz A/S Drugstore ChainsRetail Trade Sandoz A/S engages in sale and distribution of pharmaceutical products. It offers a variety of prescription medicines, Over-the-Counter medicines, and biopharmaceuticals. The company was founded in 2004 and is headquartered in Copenhagen, Denmark. | Retail Trade |
| Medicines For Europe | |
| Intergenerika |
- Stock Market
- Insiders
- Rebecca Guntern Flückiger
